SGX Market Updates By SGX My Gateway

SGX Market Information

SGX My Gateway Market Updates

Singapore Most Traded Stocks Average 7% Total Return in November, on S$700M of Net Institutional Fund Inflow

01 December 2022

The Straits Times index (STI) booked a 7% total return in November. The Consumer Cyclical Sector led the most traded stocks over the month with Genting Singapore, Jardine C&C, NIO Inc, The Hour Glass, Parkson Retail Asia and mm2 Asia averaging 15% total returns. Jardine Cycle & Carriage traded 25x its usual trading turnover with S$119 million of net institutional fund inflow with the stock added to the MSCI Singapore Free Index on 30 Nov. SingTel has booked the most net institutional fund inflow over the past 11 months.

SGX Sectors & Stocks That Led the Past Month's Net Fund Inflows

SGX My Gateway

22 November 2022

Among these 100 stocks, the 10 stocks that saw the most net institutional fund inflows proportionate to their current market capitalisation, included 4 Technology stocks – Frencken, UMS, iFAST and Venture Corp, in addition to Sembcorp Marine, CDL Hospitality Trusts, UOB, Acesian Partners, Genting Singapore, and Yangzijiang Shipbuilding.

S-REITs' Discount to Book Value Narrows on Global Rate Outlook

SGX My Gateway

21 November 2022

The most defensive REITs and property trusts in the 2022-to-date included CDL Hospitality Trusts, Far East Hospitality Trust, Sabana Industrial REIT, CapitaLand Integrated Commercial Trust and Suntec REIT. Over the past 5 years, there have only been 6 weeks when the P/B ratio of the FTSE ST REIT Index ended the week below 0.90x

Wilmar, Sembcorp Industries & Keppel DC REIT Led STI’s 2-Week Rebound

SGX My Gateway

07 November 2022

The STI’s 5 strongest stocks since 21 Oct included Wilmar International, Sembcorp Industries, Keppel DC REIT, UOB and Keppel Corp, with four of the five stocks providing financials or business updates over the period. UOB was among the most defensive STI stocks between 13 Sep and 21 Oct, in addition to Yangzijiang Shipbuilding, Genting Singapore, DBS, Emperador.

Mixed Returns For Singapore's Most Traded Non-STI Stocks In October 2022

SGX My Gateway

31 October 2022

Singapore’s 30 most traded non-STI stocks have seen ~S$670 million in net institutional fund outflows in the 2022 year-to-date. The most defensive of this 30 stocks for October ahead of the final session for the month, included Sembcorp Marine, Golden Energy & Resources, CapitaLand India Trust, Geo Energy Resources, First Resources, RH Petrogas, Golden Agri-Resources and iFAST.

Technology Stocks Take Spotlight On US Trade Policy & Growth Outlook

SGX My Gateway

17 October 2022

In Singapore, the 10 most traded stocks relevant to the Technology Sector have averaged 33% declines in total return this year with S$323mil net institution fund outflows. Both AEM (SGX:AWX) and UMS (SGX:558) have now trimmed their total returns since the end of 2019 to 68% and 37% respectively, with both companies reporting record revenue growth in 1H22. Silverlake Axis (SGX:5CP) has defied the downtrend in the technology-related plays in the 2022 year thus far, generating a 16% total return.

Share Buyback Consideration Of SGX Primary Listings Total S$586m In 3Q22

SGX My Gateway

06 October 2022

In 3Q22, 46 SGX primary-listed companies bought back shares with a total consideration of S$586 million, bringing the total buyback consideration for the first 9 months of 2022 to S$1.54 billion. Non-STI stocks with the highest 3Q22 buyback consideration included Yangzijiang Financial, The Hour Glass, OUE, First Resources and Hong Fok Corporation.

Singapore Net Institutional Fund Inflows In 3Q22 Led by DBS & OCBC Bank

SGX My Gateway

04 October 2022

The STI’s 2.4% total return in 3Q22 was mainly driven by the trio of DBS, OCBC and UOB, which averaged a 7.3% total return over the quarter. The trio saw S$969 million of combined net fund inflows with the net fund inflows to DBS and OCBC more than offsetting the net fund outflows booked by UOB. The Sectors that saw the next highest net fund inflows in 3Q22 were Telecommunications and Consumer Cyclicals. This was mostly driven by SingTel, and Consumer Cyclical sector driven by Genting Singapore, Jardine C&C and The Hour Glass.

Top 5 STI Heavyweights Book Average 9% Return In Quarter-To-Date

SGX My Gateway

26 September 2022

The STI’s 5 largest weights – DBS, OCBC, UOB, SingTel and Jardine Matheson make up 56% of the STI weights, and have averaged 9% quarter-to-date total returns, bringing their average year-to-date total return to 10%. For the quarter-to-date, the 5 stocks have seen combined net fund inflows S$1.25 billion.

10 SGX Listed Consumer Stocks That Averaged 11% Year-To-Date Gains On S$377m Institutional Fund Inflows

SGX My Gateway

19 September 2022

Singapore’s 5 most traded consumer cyclical stocks year-to-date include Genting Singapore, Jardine Cycle & Carriage, NIO Inc, The Hour Glass and mm2 Asia. Singapore’s 5 most traded consumer non-cyclical stocks include Wilmar International, Thai Beverage, Golden Agri-Resources, First Resources and Sheng Siong.

These articles are provided by SGX My Gateway.

SGX My Gateway

SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.

These articles are not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.